Literature DB >> 23922379

Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages.

Balázs Koscsó1, Balázs Csóka, Endre Kókai, Zoltán H Németh, Pál Pacher, László Virág, S Joseph Leibovich, György Haskó.   

Abstract

The alternatively activated macrophage phenotype induced by IL-10 is called M2c. Adenosine is an endogenous purine nucleoside that accumulates in the extracellular space in response to metabolic disturbances, hypoxia, inflammation, physical damage, or apoptosis. As adenosine is known to regulate classically activated M1 and IL4- and IL-13-activated M2a macrophages, the goal of the present study was to explore its effects on M2c macrophages. We found that adenosine augmented the IL-10-induced expression of TIMP-1 and arginase-1 by the mouse macrophage cell line RAW 264.7 and by mouse BMDMs. The effects of AR stimulation on IL-10-induced TIMP-1 or arginase-1 expression were lacking in A2BAR KO macrophages. The role of A2BAR on TIMP-1 production of RAW 264.7 cells was confirmed with specific agonist BAY606583 and antagonist PSB0788. AR stimulation augmented IL-10-induced STAT3 phosphorylation in macrophages, and pharmacological inhibition or silencing of STAT3 using siRNA reduced the stimulatory effect of AR stimulation on TIMP-1 production. In contrast to its stimulatory effect on IL-10-induced STAT3 activation, adenosine inhibited IL-6-induced STAT3 phosphorylation and SAA3 expression. In conclusion, adenosine enhances IL-10-induced STAT3 signaling and M2c macrophage activation.

Entities:  

Keywords:  TIMP-1; alternative activation; arginase

Mesh:

Substances:

Year:  2013        PMID: 23922379      PMCID: PMC3828607          DOI: 10.1189/jlb.0113043

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  53 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.

Authors:  D V Jovanovic; J A Di Battista; J Martel-Pelletier; P Reboul; Y He; F C Jolicoeur; J P Pelletier
Journal:  J Rheumatol       Date:  2001-04       Impact factor: 4.666

Review 3.  IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

Authors:  Markus F Neurath; Susetta Finotto
Journal:  Cytokine Growth Factor Rev       Date:  2011-03-05       Impact factor: 7.638

Review 4.  Interleukin-6 signalling: more than Jaks and STATs.

Authors:  René Eulenfeld; Anna Dittrich; Christina Khouri; Pia J Müller; Barbara Mütze; Alexandra Wolf; Fred Schaper
Journal:  Eur J Cell Biol       Date:  2011-12-03       Impact factor: 4.492

5.  Interleukin-10-induced gene expression and suppressive function are selectively modulated by the PI3K-Akt-GSK3 pathway.

Authors:  Taras T Antoniv; Lionel B Ivashkiv
Journal:  Immunology       Date:  2011-01-24       Impact factor: 7.397

Review 6.  Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.

Authors:  Peter J Murray
Journal:  Curr Opin Pharmacol       Date:  2006-05-18       Impact factor: 5.547

7.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Authors:  Maciej Kujawski; Marcin Kortylewski; Heehyoung Lee; Andreas Herrmann; Heidi Kay; Hua Yu
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

9.  Akt regulates IL-10 mediated suppression of TNFα-induced cardiomyocyte apoptosis by upregulating Stat3 phosphorylation.

Authors:  Sanjiv Dhingra; Ashim K Bagchi; Ana L Ludke; Anita K Sharma; Pawan K Singal
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

10.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

View more
  62 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Authors:  Lindsay L Jones; Rajshekhar Alli; Bofeng Li; Terrence L Geiger
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

3.  G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b.

Authors:  Hong-Mei Li; Ji Hye Jang; Jun-Sub Jung; Jiseon Shin; Chul O Park; Yeon-Ja Kim; Won-Gyun Ahn; Ju-Suk Nam; Chang-Won Hong; Jongho Lee; Yu-Jin Jung; Jiang-Fan Chen; Katya Ravid; H Thomas Lee; Won-Ki Huh; Janusz H Kabarowski; Dong-Keun Song
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

Review 4.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

5.  Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer.

Authors:  Saly Al-Taei; Josephine Salimu; Lisa K Spary; Aled Clayton; Jason F Lester; Zsuzsanna Tabi
Journal:  Oncoimmunology       Date:  2016-12-08       Impact factor: 8.110

Review 6.  Adenosine metabolism, immunity and joint health.

Authors:  György Haskó; Luca Antonioli; Bruce N Cronstein
Journal:  Biochem Pharmacol       Date:  2018-02-07       Impact factor: 5.858

7.  Anti-CD73 in cancer immunotherapy: awakening new opportunities.

Authors:  Luca Antonioli; Gennady G Yegutkin; Pál Pacher; Corrado Blandizzi; György Haskó
Journal:  Trends Cancer       Date:  2016-02-01

Review 8.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

9.  Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.

Authors:  Qiang Li; Xiaoning Han; Xi Lan; Xiaohua Hong; Qian Li; Yufeng Gao; Tianqi Luo; Qingwu Yang; Raymond C Koehler; Yu Zhai; Jinyuan Zhou; Jian Wang
Journal:  Neurobiol Dis       Date:  2017-08-19       Impact factor: 5.996

10.  Alternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage.

Authors:  Che-Feng Chang; Jieru Wan; Qiang Li; Stephen C Renfroe; Nicola M Heller; Jian Wang
Journal:  Neurobiol Dis       Date:  2017-03-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.